On the other hand, the "operative" word in "may be headed back" is "MAY"! In CTTC's case, I think the probability is considerably HIGHER that it MAY head towards ZERO!
Even aside from lawsuits out the wazoo, liens on inventory and EVERYTHING of value, NO new clinical trials to prepare for a "PMA," no new GSA contracts, no third party reimbursement, and a CEO likely lying DEAD somewhere, aren't the kind of stuff to build a long term rally on -- wouldn't you agree?
On top of all THAT, now poor (and I do mean "POOR") old Cooney -- he of "climbing mountains in the dark...barefoot...in the rain" to get money from third party reimbursers -- is now providing calmare "therapy" for FREE:
"Things are humming along here at the clinic with a steady stream of patients from around the globe. But we’d like to offer this treatment to as many people as we can."
Uh-huh! Yeah! Sure! Got patients lined up around the block I bet! So, naturally, you decided to try to CON a few more in by offering FREE therapy. Pardon me a sec while I go slip on a pair of hip boots!
Oh! And then comes this gem:
"While I have an outstanding staff, this is a ‘provider dependent’ treatment particularly useful in the treatment of these conditions..."
Hmmmmmm...that can't be very encouraging for any potential calmare purchasers! How does a customer determine whether he'll "measure up"? Be kind of annoying to shell out 60 plus grand only to find you flunk the "provider dependent" test!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.